Downregulation of miR-145 alleviates ox-LDL-induced inflammation by targeting QKI in macrophages

Xueqiang Feng1, Fuwang Yao2, Yuqin Lang3

  • 1Department of Vascular Intervention, Affiliated Hospital of Weifang Medical University Weifang, Shandong Province, China.

Abstract

Insights

MicroRNA-145 (miR-145) exacerbates atherosclerosis by increasing inflammatory cytokines and macrophage proliferation. Targeting miR-145 offers a potential therapeutic strategy for atherosclerosis.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Cardiovascular disease research

Background:

  • Atherosclerosis (AS) is a significant cause of mortality.
  • MicroRNAs (miRNAs) are implicated in AS pathogenesis.
  • miR-145's role in AS requires further elucidation.

Purpose of the Study:

  • To investigate the impact of miR-145 on atherosclerosis development.
  • To explore the regulatory mechanisms of miR-145 in macrophage activation and inflammation.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and ELISA to measure cytokine expression (IL-6, IL-1β, TNF-α).
  • Cell Counting Kit-8 (CCK-8) assay to assess macrophage proliferation.
  • Luciferase reporter assay to analyze miR-145's effect on QKI transcriptional activity.

Main Results:

  • Overexpression of miR-145 increased IL-6, IL-1β, and TNF-α levels.
  • Down-regulation of miR-145 inhibited macrophage proliferation and inflammatory cytokine expression.
  • Inhibition of miR-145 partially reversed inflammatory factor expression by targeting QKI.

Conclusions:

  • miR-145 regulates macrophage-induced inflammatory responses by targeting QKI.
  • Modulating miR-145 presents a potential therapeutic avenue for atherosclerosis.